A Phase I Clinical Trial on Decitabine (5-aza-2'-Deoxycytidine) Administered by Hepatic Arterial Infusion in Patients With Unresectable Liver-predominant Metastases From Colorectal Cancer

Trial Profile

A Phase I Clinical Trial on Decitabine (5-aza-2'-Deoxycytidine) Administered by Hepatic Arterial Infusion in Patients With Unresectable Liver-predominant Metastases From Colorectal Cancer

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Oct 2017

At a glance

  • Drugs Decitabine (Primary)
  • Indications Colorectal cancer; Liver cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 25 Oct 2017 Status changed from recruiting to completed.
    • 14 Sep 2016 Planned End Date changed from 1 Jul 2016 to 1 Jul 2017.
    • 14 Sep 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Dec 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top